Paul Hallenbeck

Company: Seneca Therapeutics Inc.

Job title: Founder, President & Chief Executive & Scientific Officer

Seminars:

Roundtable Discussion: Explore the Key Features of Designing Your Clinical Trials: Navigating the Pathway to Successful Clinical Translation & Market Approval 1:30 pm

Evaluating the role of CMC in clinical trial design and execution Developing robust processes for CMC to ensure consistent quality control throughout the trial Analyzing the impact of different trial designs, such as phase I, II, and III studies, on CMC considerations Overcoming challenges in selecting appropriate control arms and randomization strategies while considering CMC…Read more

day: Pre-Conference Day

Assessing the Benefits & Challenges of Intravenous Delivery of Oncolytic Viruses 11:00 am

How can we continue to deliver the virus intravenously? How can we overcome the body clearing the virus when delivered intravenously? What is the best way to conceal the virus in the bloodstream to avoid clearing and allowing it to cross into the tumor? What are the strategies to enhance viral circulation, evasion of neutralizing…Read more

day: Day One